Kaposi’s sarcoma before and during a human immunodeficiency virus epidemic in Tanzanian children
Authors:
- Ephata E. KaayaEKEphata E. Kaaya
- Karim P. ManjiKMKarim P. Manji
- Gideon KwesigaboGKGideon Kwesigabo
- Peter BiberfeldPBPeter Biberfeld
- 1 May 2001
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 20 (5) , 518-521
Abstract
With the onset of AIDS increased frequency of Kaposi’s sarcoma (KS) has been reported. However, there is no case-based comparison of childhood (<14 years) KS before and during the HIV pandemic in sub-Saharan Africa. Here we report on the Tanzanian cancer registry data of pediatric KS in Tanzania and implications with regard to pathogenic factors. One hundred fifty histologically confirmed pediatric KS (PKS) cases registered during 1968 through 1995 (28 years) were analyzed with regard to demographic and clinical characteristics before and during the AIDS epidemic. Statistical analysis was done with the Epi-Info program and chi square test. Of children with PKS 126 (84%) were male and 24 (16%) were female. The gender ratio was 5.1:1 and 5.4:1 during the endemic and epidemic periods, respectively. The highest occurrence of PKS was observed in the 0- to 5-years age group. Overall 73 (4.9/year) of these cases were registered during the pre and 77 (5.9/year) during the AIDS period. Over time a significant increase in anatomically disseminated KS cases was evident during the AIDS epidemic (P = 0.003). These observations indicate that children younger than 5 years are at high risk for developing KS, possibly reflecting low resistance to human herpesvirus (HHV) 8 infection. It is also likely that an increased susceptibility to HHV8 infection and morbidity is related to progressive immunodeficiency. The increase in AIDS PKS incidence appears to reflect a direct or indirect promoting effect of HIV on the development of KS lesions. Recognition of the high KS risk in small children warrants considerations of possible prevention measures including HIV/HHV8 vaccination and therapeutic options.Keywords
This publication has 18 references indexed in Scilit:
- Kaposi sarcoma-associated herpesvirus/human herpesvirus 8, cytokines, growth factors and HIV in pathogenesis of Kaposiʼs sarcomaCurrent Opinion in Infectious Diseases, 1998
- Risk factors for Kaposiʼs sarcoma in HIV-positive subjects in UgandaAIDS, 1997
- Recent upturn in mortality in rural ZimbabweAIDS, 1997
- Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study GroupArchives of internal medicine (1960), 1996
- Childhood cancers in Zambia before and after the HIV epidemic.Archives of Disease in Childhood, 1995
- Epidemiologic clues to the etiology of Kaposiʼs sarcomaAIDS, 1993
- AIDS-associated Kaposi's sarcoma in Romanian childrenJournal of the American Academy of Dermatology, 1993
- HIV-1 neutralization directed to epitopes other than linear V3 determinantsAIDS, 1991
- Cutaneous acquired immunodeficiency syndrome-associated Kaposi's sarcoma in pediatric patientsArchives of Dermatology, 1990
- Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcomaJournal of the American Academy of Dermatology, 1990